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a  b  s  t  r  a  c  t
Antisynthetase Syndrome (ASS) is characterized by myositis, Raynaud’s phenomenon, fever,
interstitial lung disease, mechanic’s hands and arthropathy associated with the presence
of  antibodies against tRNA synthetase, especially anti-Jo-1. This article aims to review the
literature on ASS and report two cases where the ﬁrst is a patient with polymyositis who
developed subluxation on the proximal interphalangeal joint of bilateral ﬁrst right ﬁnger
after a few years of the disease, associated with pulmonary manifestations and positive
anti-JO-1. In the second case, we present a patient with dermatomyositis, who developed
a  subluxation of the two ﬁrst ﬁngers, anti-Jo1 positive and chest CT changes, but without
clinical evidence of pulmonary involvement. These cases reveal the importance of perform-
ing  early diagnosis. The authors describe two cases of this rare syndrome, emphasizing the
severity of interstitial lung disease and arthritis.
© 2014 Elsevier Editora Ltda. All rights reserved.
Síndrome  Antissintetase:  relato  de  dois  casos  e  revisão  da  literatura
alavras-chave:
índrome antissintetase
olidermatomiosite
r  e  s  u  m  o
A Síndrome Antissintetase (SAS) é caracterizada por miosite, fenômeno de Raynaud, febre,
doenc¸a  pulmonar intersticial, artropatia e mãos de mecânico associados à presenc¸a de anticor-
pos  contra a sintetase do RNAt especialmente anti-Jo-1. Este artigo tem como objetivo revisar
nti-Jo 1
oenc¸a intersticial pulmonar
a  literatura sobre SAS e relatar dois casos, sendo o caso 1 de uma paciente com Polimiosite
que  desenvolveu, após alguns anos de doenc¸a, subluxac¸ão da articulac¸ão interfalangeana
proximal do primeiro quirododáctilo direito, associada a manifestac¸ões pulmonares e anti-
Jo-1  positivo. O caso 2 é de uma paciente com Dermatomiosite que evoluiu com subluxac¸ão
dos dois primeiros quirodáctilos, anti-Jo-1 positivo e alterac¸ões pulmonares intersticiais na
 Study conducted at Department of General Medicine, Gaffré and Guinle University Hospital, School of Medicine and Surgery, Univer-
idade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
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ttp://dx.doi.org/10.1016/j.rbre.2013.05.006
255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.
178  r e v b r a s r e u m a t o l . 2 0 1 5;5 5(2):177–180
TC de tórax, porém assintomática. Esses casos demonstram a importância do diagnóstico
precoce. Os autores descrevem dois casos dessa síndrome rara, enfatizando a sua gravidade
do  ponto de vista pulmonar e articular.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
Fig. 1 – Bilateral subluxation of distal interphalangeal jointsIntroduction
Idiopathic inﬂammatory myopathies are a heterogeneous
group of acquired muscular diseases characterized by var-
ious types and degrees of skeletal muscle inﬂammation.1
Polymyositis (PM) and dermatomyositis (DM) are the two
major conditions making up this group of diseases. They
are associated with serum antibodies related to particular
clinical manifestations, therefore marking important clinical
subgroups. The largest subgroup in muscular inﬂammatory
diseases comprises the Antisynthetase Syndrome (ASS), ﬁrstly
described by Marguerie et al. in 1990 as the triad polymyosi-
tis, diffuse interstitial lung disease, and self-antibodies to
aminoacyl-tRNA synthetase (anti-ARS). It is currently charac-
terized by the production of antibodies to tRNA synthetase,
with anti-Jo-1 being the best known of these antibodies asso-
ciated with myositis, interstitial lung disease, joint disease,
fever, Raynaud’s phenomenon and “mechanic’s hands”.2,3
This is a rare disease with an incidence in general popula-
tion that is still unknown and a twofold higher prevalence in
females. The interstitial lung disease (ILD) is the main mor-
bidity and mortality determinant in the syndrome.
Case  1
A white craftswoman aged 61 with Hashimoto’s thyroiditis
was seen in the rheumatology clinic in January 2001 repor-
ting some manifestations that were consistent with Raynaud’s
phenomenon, but she did not have muscle weakness or joint
pain. A number of laboratory tests were obtained and the
results are as follows: LDH: 628 (RV: 115–225); CK: 1041 (RV:
96–140); aldolase: 20.6 (RV: 3–7); ALT: 20 (RV: 7–56); AST: 36 (RV:
5–40); rheumatoid factor (RF): 12 (RV = up to 20), antinuclear
antibody (ANA): negative; anti-Jo-1: positive; chest X-ray: no
abnormalities were seen. Corticosteroids were initiated and
muscle enzymes were normalized 4 months later. In January
2002, the patient complained of dyspnea and the chest X-ray
showed a bilateral lung base inﬁltrate, in addition to elevated
muscle enzymes. In May 2002, a chest computed tomography
(CT) was obtained and diffuse “ground glass” imaging was
seen, in addition to a pulmonary function test exhibiting a
restrictive pattern. At that time, the patient complained of
fever. In 2004, she had an interstitial thickening of the right
upper lobe and both bases on chest X-ray, with dense bands
showing a residual ﬁbrous appearance in the right lower lobe.In 2007, due to a respiratory and laboratory worsening, a
monthly pulse therapy with cyclophosphamide was initiated.
In that very year, she had a synovitis at the ﬁrst ﬁnger of the
right hand, progressing to a bilateral proximal interphalangeal(case 2).
subluxation of the ﬁrst ﬁnger. Hand X-ray: slightly reduced
carpometacarpal joint space.
Case  2
A white female patient aged 78, born in Portugal and who
retired as an embroiderer, presented with a classic dermato-
myositis since 1980. She had used corticosteroids for 11
years, with symptom remission (proximal muscle weakness,
heliotrope rash, Gottron’s papules, Raynaud’s phenomenon,
joint pain, and skin rash). Remission was maintained. Five
years earlier, she had presented a deformity with distal inter-
phalangeal joint subluxation of the ﬁrst ﬁngers (Fig. 1). A hand
X-ray in 2009 showed bilateral interphalangeal (IP) arthrosis
signs from the 2nd to the 5th ﬁnger and at the thumb IP,
unilateral rizarthrosis and right pyramidal osteophytes. Chest
CT: slight reticular pattern, subpleural lines, and ground glass
opacities in the lung periphery. Positive anti-Jo-1.
Discussion
The Antisynthetase Syndrome is characterized by myosi-
tis, interstitial lung disease, joint pain, arthritis, “mechanic’s
hands”, fever, and Raynaud’s phenomenon. It is associated
with self-antibodies to tRNA synthetase, mainly anti-Jo-1. In
general, the myositis either precedes or is concomitant with
the lung involvement, as in the ﬁrst reported case, in which the
patient only had Raynaud’s phenomenon, elevated enzymes
(LDH, CK, and aldolase) and positive anti-Jo-1, manifesting
dyspnea and chest CT changes with diffuse ground glass imag-
ing and restrictive pattern on the PFT. The patient in case 2,
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n turn, reported no respiratory complaints, but her chest CT
as also demonstrated similar changes (Fig. 2).
Lung impairment is found in over 60% of the cases and
s the major morbidity cause.4 Therefore, in some cases, the
nterstitial lung disease is predominant in the Antisynthetase
yndrome. The interstitial disease can have a slow onset and
ead to acute respiratory failure, sometimes highly refractory
o treatment.5
Adult respiratory distress syndrome, bronchiolitis obliter-
ns organizing pneumonia (BOOP), and ﬁbrosing alveolitis are
ssociated with ILD.6 Lung manifestations include dyspnea,
ough, thoracic pain, physical exercise intolerance and respi-
atory failure.
Radiological imaging of lungs can reveal an interstitial pat-
ern, and ground grass lesions, linear opacities, pulmonary
arenchyma consolidations, and micronodules can also be
een on the computed tomography. The pulmonary function
est shows a restrictive pattern. The patients with BOOP usu-
lly have a more  favorable prognosis compared with those
ith either diffuse alveolar lesions or interstitial pneumonia.
nti-Ro antibodies presence has been associated with pul-
onary ﬁbrosis in the Antisynthetase Syndrome.7–9
Joint involvement affects 50% of the cases with joint pain or
rthritis with or without bone erosions. All the patients had
oint symptoms early in the disease.5 Typically, the arthritis
n idiopathic inﬂammatory myopathies is light, nondeform-
ng, and nonerosive,10 although a subgroup of patients might
evelop an erosive and/or subluxing joint disease. The fol-
owing joints are commonly affected: distal and proximal
nterphalangeal joints, metacarpophalangeal joints, wrists,
lbows, and knees.
Meyer et al.11 described 40 patients with ASS and joint
anifestations and they were classiﬁed into three cate-
ories: subluxing joint disease of thumb distal interphalangeal
oints (n = 6); symmetrical polyarthritis with or without erosion
n = 24) and isolated arthralgia (n = 10). Oddis et al.12 described
onerosive joint disease of proximal and distal interpha-
angeal joints (ﬂoppy thumb).Both our cases had a subluxing joint disease of interpha-
angeal joints (case 1: PIPJ of the ﬁrst ﬁnger; case 2: DIPJ of the
rst ﬁnger). 5;5 5(2):177–180 179
Raynaud’s phenomenon is early in 2/3 of patients and can
precede the myositis in years. It is more  frequently found in
anti-Jo-1-positive patients.3
“Mechanic’s hands” are a hyperkeratosis, scaling, and ﬁs-
sure in ﬁngertips and lateral aspects of the ﬁngers, being more
frequently found in the Antisynthetase Syndrome and inter-
stitial lung disease.
A skin vasculitis has also been described. The heart
involvement does not have a different prevalence from that
in polymyositis/dermatomyositis. A mesangial proliferative
glomerulonephritis has been observed, but it is rare and
has a good prognosis.13 Regarding idiopathic inﬂammatory
myopathies associated with a interstitial lung lesion, recent
reports show a favorable response to prednisone: 30–40% of
the patients had an improvement and 20–40% became sta-
ble for symptoms and pulmonary function. A small group of
patients is resistant to corticosteroids. There are remission
reports with azathioprine, methotrexate, cyclophosphamide,
cyclosporine, tacrolimus or mycophenolate mofetil.1,14 A late
relapse following an initial remission is more  common in the
Antisynthetase Syndrome.
Brulhart et al. described a patient aged 57 with an Anti-
synthetase Syndrome treated by prednisone (high doses) and
methotrexate 15 mg/week who had a good response. A severe
clinical and laboratory relapse was seen three months later.
Rituximab (2 × 1-g infusions) was introduced, with myositis
and ILD improvement.9 Studies suggest that CD20 deple-
tion therapy might be valuable in refractory Antisynthetase
Syndrome.14
Anti-Jo-1-positive myopathies have a worse prognosis than
other inﬂammatory myopathies.15
Tests for anti-Jo-1 should be obtained in patients with
inﬂammatory muscle disease, as well as a screening for inter-
stitial lung disease.3
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